Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neurobiology of Disease|October 27, 2006
Abnormal latent inhibition and impulsivity in coloboma mice, a model of ADHDKristy J Bruno, Christopher S Freet, Robert C Twining, et al.
Brain Research Bulletin|September 19, 2022
Prefrontal cortical response to natural rewards and self-reported anhedonia are associated with greater craving among recently withdrawn patients in residential treatment for opioid use disorderDaniel J Petrie, Kyler S Knapp, Christopher S Freet, et al.
Brain Research Bulletin|August 29, 2022
Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking ratsBrianna Evans, Brooke Stoltzfus, Nikhil Acharya, et al.
Physiology & Behavior|April 17, 2016
The role of dose and restriction state on morphine-, cocaine-, and LiCl-induced suppression of saccharin intake: A comprehensive analysisRobert C Twining, Christopher S Freet, Robert A Wheeler, et al.
Behavioural Pharmacology|June 2, 2026
Acute glucagon-like peptide-1 receptor agonist, semaglutide, attenuates cue-, drug-, and stress-induced fentanyl seeking in male Sprague-Dawley ratsBrianna Evans, Nikhil Acharya, Christopher G Brandl, et al.
Substance Use & Misuse|March 21, 2025
Contemporaneous Link Between Pain and Craving in Patients Recovering from Prescription Opioid Use Disorder During Residential TreatmentDaniel J Petrie, Kyler S Knapp, Christopher S Freet, et al.
Drug and Alcohol Dependence|August 15, 2021
Reregulation of cortisol levels and sleep in patients with prescription opioid use disorder during long-term residential treatmentDahlia Mukherjee, Dean M Stankoski, Sarah E Tilden, et al.
Physiology & Behavior|December 3, 2014
Cocaine-induced suppression of saccharin intake and morphine modulation of Ca²⁺ channel currents in sensory neurons of OPRM1 A118G miceChristopher S Freet, Sarah M Ballard, Danielle N Alexander, et al.
Scientific Reports|October 3, 2019
The Human Transient Receptor Potential Melastatin 2 Ion Channel Modulates ROS Through Nrf2Lei Bao, Fernanda Festa, Christopher S Freet, et al.
Addiction Science & Clinical Practice|October 31, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
Pageof 3